OHSU in the news

High risk, low benefit for Nusinersen in adult SMA?

Medscape July 27, 2020
An article covers new research led by Chafic Karam, M.D., regarding a new treatment for spinal muscular atrophy. He says, “We think there is no dramatic improvement with nusinersen treatment, maybe only modest benefits, and it comes with its own risks that must be explained clearly to the patient.”

Seven ways telehealth is changing healthcare, likely forever

The Oregonian July 26, 2020
Mark Lovgren, M.B.A., and Alison Loh, M.D., discuss OHSU’s increased telehealth offerings and Winston Chamberlain, M.D., describes how digital technology use can led to dry eye in a healthcare and technology supplement of The Oregonian.
See more stories